Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Futura MedicalFAMDF -60.00% Pretax Margin % is -342.60% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 941 Biotechnology companies, Futura Medical ranks worse than 70.99% on this metric.
The historical rank and industry rank for Futura Medical's Pretax Margin % or its related term are showing as below:
FAMDF'
s Pretax Margin % Range Over the Past 10 Years
Min: -34815.63 Med: -933.52 Max: 9.27
Current: -534.53
FAMDF's Pretax Margin % is ranked worse than 70.99% of 941
companies
in the Biotechnology industry
Industry Median: -89.42
vs FAMDF: -534.53
Futura Medical (OTCPK:FAMDF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Futura Medical Pretax Margin % Related Terms
Futura Medical Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Futura Medical's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FAMDF vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Futura Medical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Futura Medical Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Futura Medical's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Futura Medical's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Futura Medical (FAMDF) has a Pretax Margin % of -342.60% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Futura Medical and its competitors. According to the industry distribution chart, Futura Medical ranks #668 out of 941 companies in the Biotechnology industry, placing it in the top 71%.
Is Futura Medical's Pretax Margin % too high?
Futura Medical's current Pretax Margin % is -342.60%. Based on the distribution chart, Futura Medical ranks #668 out of 941 companies in the Biotechnology industry, which is below the industry midpoint.
How does Futura Medical's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Futura Medical ranks #668 out of 941 companies for Pretax Margin %. This places Futura Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Futura Medical and its competitors. Futura Medical's current Pretax Margin % is -342.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Futura Medical stock overvalued right now?
Based on GuruFocus' analysis, Futura Medical (FAMDF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.08, compared to a current price of $0.00 — trading 95% below its estimated fair value. The current Pretax Margin % is -342.60%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Futura Medical (FAMDF), the current Pretax Margin % is -342.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FAMDF has been successfully added to your 
